Synthesis and characterization of copper–based anticancer compound; in vitro interaction studies with DNA/HSA, SOD mimetic, cytotoxic activity and molecular docking investigation
A new copper(II) complex derived from the ligand ethylene [O,O'-bis{5-{(1E)-(2 hydroxyphenyl)methylene]amino} - 2-hydroxybenzoic acid] was designed, synthesized and characterized by spectroscopic (IR, UV-Vis, ESI-MS, X-ray diffraction, EPR and elemental analytical methods